Biotinylated Mouse PVRIG Protein, Active
Beta LifeScience
SKU/CAT #: BLK-01144P-100UG
Biotinylated Mouse PVRIG on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Biotinylated Mouse PVRIG Protein, Active
Beta LifeScience
SKU/CAT #: BLK-01144P-100UG
Collections: Co-inhibitory receptors, Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Biotinylated Mouse PVRIG Protein is expressed from HEK293 with hFc tag and Avi tag at the C-Terminus.It contains Ser35-Asp165. |
Purity | > 95% as determined by Tris-Bis PAGE |
Accession | A0A1B0GS01 |
Target Symbol | PVRIG |
Species | Mouse |
Expression System | HEK293 |
Tag | C-hFc-Avi |
Expression Range | Ser35-Asp165 |
Mol. Weight | The protein has a predicted MW of 42.7 kDa. Due to glycosylation, the protein migrates to 55-65 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Mouse Nectin-2, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Mouse PVRIG, hFc Tag with the EC50 of 1.76ug/ml determined by ELISA (QC Test). The affinity constant of 2.22 uM as determined in SPR assay (Biacore T200). Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Murine PVRIG interacted weakly with poliovirus receptor (PVR) but bound poliovirus receptor-like 2 (PVRL2) strongly, making the latter its principal ligand.PVRIG is an inducible checkpoint receptor and that targeting PVRIG-PVRL2 interactions results in increased CD8+ T-cell function and reduced tumor growth. |